You are here

  • Home
  • Archive
  • Volume 86, Issue 11
  • PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY

Article metrics

Article menu
Download PDFPDF
ABN abstracts 2015 ABN Annual Meeting, 10 September 2015, Institute of Education, London
Wed 20, Parallel session 4: Disease pathophysiology
027
PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY

 

Online download statistics by month:

Online download statistics by month: October 2015 to March 2024

AbstractFullPdf
Oct 20155004
Nov 201559011
Dec 20153400
Jan 20162801
Feb 20161801
Mar 20162504
Apr 20163303
May 201624020
Jun 2016602
Jul 20161501
Aug 20161102
Sep 20161900
Oct 20162000
Nov 201624026
Dec 2016800
Jan 20171400
Feb 20171100
Mar 2017601
Apr 2017901
May 20171402
Jun 20171601
Jul 20171000
Aug 20172000
Sep 20172600
Oct 20176604
Nov 20175802
Dec 20176400
Jan 20182401
Feb 20186300
Mar 20184000
Apr 20183201
May 20184800
Jun 20182200
Jul 20183400
Aug 20182202
Sep 20184003
Oct 20185800
Nov 20185801
Dec 20183800
Jan 20192502
Feb 20191600
Mar 2019600
Apr 20191100
May 20191201
Jun 20191000
Jul 20192202
Aug 2019400
Sep 2019800
Oct 20191200
Nov 2019802
Dec 20191001
Jan 20201600
Feb 20201201
Apr 2020800
May 20202600
Jun 20201003
Jul 20201400
Sep 20204400
Oct 20202100
Nov 20205000
Dec 20202000
Jan 2021603
Feb 20212000
Mar 20212800
Apr 20212201
Oct 20211800
Nov 2021800
Dec 2021800
Jan 20221003
Feb 20221000
Mar 20221200
Apr 20222101
May 20223200
Jun 20223001
Jul 20221800
Aug 20222600
Sep 20224002
Oct 20223800
Nov 20221200
Dec 20222000
Jan 20234001
Feb 20233401
Mar 20232000
Apr 2023200
May 20231200
Jun 20231000
Jul 20231000
Aug 20231000
Sep 20231600
Oct 20231400
Nov 20231201
Dec 20232400
Jan 20241001
Feb 20241400
Mar 2024200
Total21410121